Acute treatment of atrial fibrillation

The American Journal of Cardiology
P R KoweyR A Filart

Abstract

Atrial fibrillation (AFib) is a common clinical entity, responsible for significant morbidity and mortality, but it also accounts for a large percentage of healthcare dollar expenditures. Efforts to treat this arrhythmia in the past have focused on subacute antithrombotic therapy and eventually use of antiarrhythmic drugs for maintenance of sinus rhythm. However, there has been a growing interest in the concept of acute electrical and pharmacologic conversion. This treatment strategy has a number of benefits, including immediate alleviation of patient symptoms, avoidance of antithrombotic therapy, and prevention of electrophysiologic remodeling, which is thought to contribute to the perpetuation of the arrhythmia. There is also increasing evidence that this is a cost-effective strategy in that it may obviate admission to the hospital and the cost of long-term therapy. This article represents a summary of the treatments that may be used acutely to control the ventricular response to AFib, prevent thromboembolic events, and provide for acute conversion either pharmacologically or electrically. It includes information on modalities that are currently available and those that are under active development. We anticipate that an acti...Continue Reading

References

Dec 1, 1975·American Heart Journal·W J MandelW Daley
Apr 1, 1991·Annals of Internal Medicine·R H Falk, J I Leavitt
Sep 15, 1990·The American Journal of Cardiology·C J MurdockC R Kerr
Aug 25, 1988·The American Journal of Cardiology·J J GoyU Sigwart
May 1, 1988·The American Journal of Cardiology·P R Kowey
Aug 1, 1988·Journal of the American College of Cardiology·S LevyP Bru
Jun 1, 1986·Annals of Internal Medicine·H J Wellens
Jan 1, 1980·Stroke; a Journal of Cerebral Circulation·S LavyP Levy
Nov 1, 1995·American Heart Journal·S Nattel
Jan 1, 1994·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·A D CochraneB B Davis
Jan 1, 1995·Duodecim; lääketieteellinen aikakauskirja·M O Halinen

❮ Previous
Next ❯

Citations

Nov 24, 1998·Pacing and Clinical Electrophysiology : PACE·G BorianiB Magnani
Sep 25, 2002·Clinical Cardiology·Mithilesh Kumar DasMajesh Makan
Jul 11, 2006·European Journal of Clinical Pharmacology·Dagmar BusseKari T Kivistö
Dec 22, 2006·Journal of Clinical Nursing·Geraldine Lee
Dec 24, 2010·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Ian G StiellLisa A Calder
Mar 10, 2004·Journal of Cardiovascular Electrophysiology·Peter R KoweyDusan Z Kocovic
Jan 15, 2011·Journal of the American College of Cardiology·A John CammUNKNOWN AVRO Investigators
Nov 24, 2011·International Journal of Cardiology·Christian Torp-PedersenGregory N Beatch
Jun 6, 2014·Critical Care Research and Practice·Alain RudigerDominique Bettex
Aug 30, 2017·European Heart Journal. Acute Cardiovascular Care·Hanna Pohjantähti-MaaroosJuha Hartikainen
Mar 12, 2008·Circulation·Denis RoyUNKNOWN Atrial Arrhythmia Conversion Trial Investigators
Sep 4, 2004·PharmacoEconomics·M P TengD P Melby
Apr 18, 2001·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·H T SieH J Wellens
Feb 10, 2000·Current Opinion in Cardiology·J T Dell'OrfanoG V Naccarelli
Dec 22, 2000·Current Opinion in Cardiology·J T Dell'Orfano, G V Naccarelli
Aug 3, 2020·Advanced Emergency Nursing Journal·Kyle A WeantGregory A Hall

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.